We serve 5-(2-Ethoxyphenyl)-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one CAS:139756-21-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-(2-Ethoxyphenyl)-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one
CAS.NO: 139756-21-1
Synonyms:
5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one
5-(2-ethoxyphenyl)-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one
5-(2-Ethoxyphenyl)-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]-7-pyrimidinone
Molecular Formula: C17H20N4O2
Molecular Weight: 312.36600
Physical and Chemical Properties:
Density: 1.26g / cm3
Boiling point: 504ºC at 760 mmHg
Melting point: 141-145ºC (lit.)
Flash point: 258.6ºC
Refractive index: 1.632
Specification:
Appearance: Light yellow powder
Purity:≥98%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Refrigerator.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Sildenafil citrate CAS:171599-83-0
Contact us for information like 5-(2-Ethoxyphenyl)-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(2-Ethoxyphenyl)-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]-7-pyrimidinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(2-ethoxyphenyl)-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one Use and application,5-(2-ethoxyphenyl)-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one technical grade,usp/ep/jp grade.
Related News: When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant.3-BROMO-2-FLUORO-4-IODOPYRIDINE manufacturer The death toll in China rose to at least 304.2-Chloro-5-fluorobenzoic acid supplier Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).3-Methylbenzonitrile vendor Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).On Friday, the Trump administration announced it will deny entry to foreign nationals who have traveled in China in the last 14 days, starting Sunday.